Skip to main content
logo
RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.68
+0.05 (0.89%)
May 15, 2026, 4:00 PM EDT - Market closed

RxSight Revenue

RxSight had revenue of $30.89M in the quarter ending March 31, 2026, a decrease of -18.48%. This brings the company's revenue in the last twelve months to $127.48M, down -14.05% year-over-year. In the year 2025, RxSight had annual revenue of $134.48M, down -3.89%.

Revenue (ttm)
$127.48M
Revenue Growth
-14.05%
P/S Ratio
1.84
Revenue / Employee
$276,523
Employees
461
Market Cap
235.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025134.48M-5.45M-3.89%
Dec 31, 2024139.93M50.85M57.09%
Dec 31, 202389.08M40.07M81.77%
Dec 31, 202249.01M26.41M116.90%
Dec 31, 202122.59M7.92M53.92%
Dec 31, 202014.68M12.44M554.98%
Dec 31, 20192.24M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen351.50M
Treace Medical Concepts207.32M
InfuSystem Holdings142.40M
Sight Sciences79.55M
Electromed71.75M
908 Devices57.80M
Senseonics Holdings40.71M
Profound Medical18.81M
Revenue Rankings

RXST News

More News